CAP Accredits CardioDx's Laboratory | GenomeWeb

NEW YORK (GenomeWeb News) – CardioDx today said that its laboratory in Palo Alto, Calif., has been accredited by the College of American Pathologists.

The company offers the Corus CAD gene expression test for evaluating patients with signs and symptoms of obstructive coronary artery disease through the laboratory, which is also CLIA certified and licensed by the State of New York.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.